Abhayjit Singh, MD, is a staff cardiologist in the Section of Preventive Cardiology & Rehabilitation at Cleveland Clinic, Cleveland, Ohio. His specialty interests include preventive cardiology, cardiovascular risk assessment and modification, coronary artery disease, hyperlipidemia, hypertension, familial hypercholesterolemia and other inherited lipid disorders.
Sodium-glucose co-transporter 2 (SGLT2) inhibitors are a newer class of medications for individuals with type 2 diabetes. While their blood-sugar-lowering ability is only moderate, other...
